Selección de longitud de onda & Profundidad de penetración del tejido en dispositivos PBM
Wavelength selection is the most critical parameter in photobiomodulation device design. Luz roja (630-660 Nuevo Méjico) targets superficial tissues (skin, heridas) by activating cytochrome c oxidase heme centers. Near-infrared (810-850 Nuevo Méjico) penetrates deeper (muscle, bone, brain) by targeting the CuA center. The therapeutic window spans 600-1000 Nuevo Méjico, with peak absorption at 660 nm y 830 Nuevo Méjico. Tissue penetration follows the optical window of 650-1350 Nuevo Méjico, […]
Fuentes de luz LED versus láser en fotobiomodulación: Una comparación técnica
LED (Diodos emisores de luz) and lasers can produce therapeutically equivalent outcomes in photobiomodulation when matched for wavelength, irradiancia, and dose. The key difference lies in coherence—lasers produce coherent (in-phase) light while LEDs emit incoherent light. Sin embargo, research shows coherence is not required for PBM’s biological effects. LEDs offer significant advantages: lower cost, larger treatment areas, no eye safety hazards, […]
Efectos posteriores del PBM: atp, Inflamación & Defensa antioxidante
Photobiomodulation triggers a cascade of downstream biological effects beginning with cytochrome c oxidase activation. Within minutes, cells experience increased ATP production (150-200%), nitric oxide release (improved blood flow), and reactive oxygen species signaling. Over hours to days, these immediate effects activate transcription factors (NF-κB, Nrf2), upregulate antioxidant defenses, modulate inflammatory cytokines (reducing TNF-α, IL-6; increasing IL-10), y […]
Respuesta a la dosis bifásica en PBM: Por qué más luz no siempre es mejor
Biphasic dose response means that photobiomodulation (Pbm) follows a characteristic curve where low doses stimulate, moderate doses produce optimal effects, and high doses inhibit cellular function. This phenomenon—also called the Arndt-Schulz curve—explains why more light is not always better. Optimal dosing typically falls in the range of 3-10 J/cm² with irradiance of 30-100 MW/cm², depending on tissue type and treatment […]
Citocromo c oxidasa: El fotoaceptor primario en la terapia con luz roja
Cytochrome c oxidase (CcO)—also known as Complex IV—is the primary photoacceptor in red and near-infrared light therapy. Located in the mitochondrial inner membrane, this enzyme absorbs photons (primarily 600-900 Nuevo Méjico), which triggers three key effects: increased ATP production (up to 150-200%), release of nitric oxide (improving blood flow), and reduced oxidative stress (mejorar la función celular). This mechanism explains the therapeutic benefits […]
Fotobiomodulación (Pbm): Definición, Mecanismo & Historia
Terapia de luz roja (RLT) is a non-invasive treatment that uses specific wavelengths of red and near-infrared light (600-1000 Nuevo Méjico) to stimulate cellular energy production, reducir la inflamación, and promote tissue repair. Also called photobiomodulation (Pbm) or low-level laser therapy (Lllt), it’s used for skin rejuvenation, alivio del dolor, recuperación muscular, hair growth, and wound healing—with clinical studies supporting its efficacy and […]